Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sterillium Virugard is a virucidal, alcohol-based hand disinfectant containing a high concentration of ethanol (95 g per 100 g). Manufactured by Bode Chemie (a subsidiary of the HARTMANN Group), it is designed for both hygienic and surgical rub-in hand disinfection, particularly in environments with an elevated risk of infection from viruses such as norovirus, adenovirus, or SARS-CoV-2. The product exerts its antimicrobial effect by denaturing microbial proteins and disrupting lipid membranes, providing broad-spectrum efficacy against bacteria, fungi, and both enveloped and non-enveloped viruses. It was notably the first alcohol-based hand disinfectant to be listed by the Robert Koch Institute (RKI) for its virucidal properties in 1995.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sterillium Virugard.